Lodaer Img

About Us

B2B pharmaceutical solutions built on trust, compliance, and innovation.

LifSa Pharma is a specialized pharmaceutical company dedicated to in-licensing, acquiring, and developing prescription and consumer healthcare products designed to help people maintain and enhance the quality of their lives and their families’ lives. We operate with the highest ethical standards and a good social conscience appropriate for a company engaged in a business that affects human lives.

Team

Leadership & Excellence

Our senior management team brings over 50 years of combined pharmaceutical experience, providing deep industry knowledge and strategic vision. We have grown through strategic business development including acquisitions, licensing, and mergers, positioning us as the partner of choice for pharmaceutical excellence.
Company Growth Strategy
We leverage our commercial excellence to identify and capitalize on opportunities across all therapeutic areas. Our focus on under-promoted branded pharmaceutical markets allows us to provide maximum value to patients, healthcare providers, and partners.
Services

Our Services

Commitment To Innovation
Our company understands that technology and medicine in the healthcare industry are consistently progressing. Our team of experienced professionals stays current with the latest drug trends, regulatory requirements, and therapeutic advances to ensure we deliver cutting-edge solutions.

Key Features:

  • Continuous monitoring of industry trends and technological advances

  • Investment in research and development capabilities

  • Strategic partnerships with leading research institutions

  • Advanced analytical and development methodologies

Drug Development & Testing
Our team constantly keeps up with medical trends and technology, striving to find better ways to improve the health of our patients in an ever-changing industry. We specialize in multiple regulatory pathways to bring effective treatments to market efficiently.

Regulatory Pathways:

  • 505(b)(2) Applications: Streamlined development for improved formulations and new indications

  • ANDA (Abbreviated New Drug Applications): Generic drug development with bioequivalence studies

  • NDA (New Drug Applications): Full development programs for novel therapeutic compounds

  • Branded Generics: Development of proprietary branded versions of off-patent medications

Pharmaceutical Manufacturing
We work with other drug developers to support clinical trials and commercial production. We maintain the highest level of safety when it comes to testing, manufacturing, and transferring of products.

Manufacturing Capabilities:

  • Good Manufacturing Practice (GMP) compliant facilities

  • Quality assurance and control systems

  • Supply chain management and distribution

  • Technology transfer and scale-up services

  • Regulatory compliance and documentation support

Assurance

Quality & Compliance

Regulatory Excellence

LifSa Pharma maintains strict compliance with all FDA regulations and guidelines. Our quality systems are designed to meet the highest standards of pharmaceutical manufacturing and distribution.

Quality Assurance

  • Current Good Manufacturing Practice (cGMP) compliance

  • Robust quality control testing programs

  • Comprehensive documentation and batch record systems

  • Regular internal and external quality audits

  • Continuous improvement programs

Safety Standards

We maintain the highest level of safety protocols across all operations:

  • Product safety monitoring and pharmacovigilance

  • Adverse event reporting systems

  • Risk management and mitigation strategies

  • Supply chain security and integrity

Process

Research & Development

Innovation Focus Areas

  • Formulation Development: Creating improved drug delivery systems

  • Lifecycle Management: Extending product value through innovation

  • Pediatric Formulations: Developing age-appropriate dosage forms

  • Fixed-Dose Combinations: Combining therapies for improved outcomes

Development Capabilities

  • Analytical method development and validation

  • Bioequivalence and clinical studies

  • Stability testing and shelf-life determination

  • Regulatory strategy and submission support